Death due to intravenous use of α-pyrrolidinopentiophenone

Medical Journal of Australia

Volumn 201, Issue 10, 2014, Pages 601-603

  Sellorsm, Kate ^a   Jones, Alison ^b,c   Chan, Betty ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c ILLAWARRA HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA PYRROLIDINOPENTIOPHENONE; BENZODIAZEPINE; BICARBONATE; CENTRAL STIMULANT AGENT; CREATINE KINASE; FIBRINOGEN; GLUCONATE CALCIUM; LACTIC ACID; UNCLASSIFIED DRUG; ALPHA-PYRROLIDINOPROPIOPHENONE; DESIGNER DRUG; PROPIOPHENONE DERIVATIVE; PSYCHOTROPIC AGENT; PYRROLIDINE DERIVATIVE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; AUTOPSY; BLOOD GAS ANALYSIS; BRAIN DEATH; BRAIN EDEMA; BRAIN HERNIA; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMODIAFILTRATION; CRYSTALLOID; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MISUSE; ELECTROCARDIOGRAPHY; GLASGOW COMA SCALE; HEART ARREST; HEART RATE; HEPATITIS; HUMAN; HYPERKALEMIA; INTRACRANIAL PRESSURE; MALE; METABOLIC ACIDOSIS; PARTIAL THROMBOPLASTIN TIME; RESPIRATORY ACIDOSIS; RESUSCITATION; RHABDOMYOLYSIS; SINUS TACHYCARDIA; TYMPANIC TEMPERATURE; CHEMICALLY INDUCED; ENCEPHALOCELE;

ADULT; CEREBRAL INFARCTION; DESIGNER DRUGS; ENCEPHALOCELE; HEART ARREST; HUMANS; MALE; PROPIOPHENONES; PSYCHOTROPIC DRUGS; PYRROLIDINES;

EID: 84925549027     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00203     Document Type: Article

References (9)

1. Sauer C, Peters FT, Haas C, et al. New designer drug alphapyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J Mass Spectrom 2009; 44: 952-964.
2. Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012; 8: 33-42.
3. Simmler LD, Buser TA, Donzelli M, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 2013; 168: 458-470.
4. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow ... and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012; 8: 15-32.
5. Ross EA, Watson M, Goldberger B. “Bath salts” intoxication. N Engl J Med 2011; 365: 967-968.
6. Marinetti LJ, Antonides HM. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 2013; 37: 135-146.
7. Murray BL, Murphy CM, Beuhler MC. Death following recreational use of designer drug “bath salts” containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 2012; 8: 69-75.
8. Vilke GM, DeBard ML, Chan TC, et al. Excited delirium syndrome (ExDS): defi ning based on a review of the literature. J Emerg Med 2012; 4 3: 897-905.
9. Bright S. New and emerging drugs. Not for human consumption: new and emerging drugs in Australia. Prev Res [internet]. 2013; Apr: 1-16. http://www.druginfo.adf.org.au/attachments/957_PreventionResearch_Newandemergingdrugs_Apr13.pdf (accessed Nov 2013).